SCHEMBL17933015

SCHEMBL17933015

Cc1ccccc1C(=O)OCC(COC(=O)c1ccccc1C)OC(=O)CCC(=O)OC(COC(=O)c1ccccc1OCc1ccccc1)COC(=O)c1ccccc1OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.52
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ PTGER1 P34995 1/20 0.45
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ RXRG P48443 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ SGMS2 Q8NHU3 2/20 0.43
▸ ADRB2 P07550 2/20 0.42
▸ ADRB1 P08588 2/20 0.42
▸ ADRB3 P13945 2/20 0.42
▸ LMNA P02545 1/20 0.41
▸ PPIA P62937 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17933018 0.97 HTT (0.49) HTTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL14430339 0.93 HTT (0.59) HTTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL14430332 0.90 HTT (0.55) HTTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL17935888 0.78 ADRB2 (0.52) MEN1KMT2ANPSR1KDM4EADRB2
SCHEMBL14430331 0.77 HTT (0.66) HTTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL340937 0.76 HTT (0.69) HTTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL14441288 0.76 ALDH1A1 (0.50) MEN1KMT2ANPSR1KDM4EADRB2
SCHEMBL14441289 0.75 MEN1 (0.51) MEN1KMT2ANPSR1KDM4EADRB2
SCHEMBL14430409 0.75 PTGS2 (0.48) MEN1KMT2AKDM4EADRB2ADRB1
SCHEMBL4415350 0.75 HTT (0.75) HTTMEN1KMT2ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170368185-A9 METHOD OF PREPARING DENDRITIC DRUGS CHAI MINGHUI (CN) 2017-12-28 — — US disclosed
US-20160206746-A1 METHOD OF PREPARING DENDRITIC DRUGS CHAI MINGHUI (CN) 2016-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160206746-A1 METHOD OF PREPARING DENDRITIC DRUGS MYD88, TLR3, TLR6 HTT 3647/4885MEN1 3220/4885KMT2A 4308/4885
US-20170368185-A9 METHOD OF PREPARING DENDRITIC DRUGS MYD88, TLR3, TLR6 HTT 3647/4885MEN1 3220/4885KMT2A 4308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback